BF Biosciences Limited
Statement of Financial Position
EQUI'I'Y AND LIABILI"F1ES
Noie
2025
Rupees2024
Rupces
Non-cii rrent assets
Note
2025
Rupee*
2024
Rupees
Authorized share capital
400,000,000 (2024: 400,000,000) ordinary
shares of Rs. 3 each (2024: Rs. 3 each)
t.2O0;000000
Property, planl and equipment
1.ong term dejxisits
/ 7 4,3U6,291,784
4,174,912,456
7,827,000
lntangibles IB 553,445
94,931,10t | 114,60 1,896 |
I ,645,285,845 | 779,210,877 |
M4,242,t6l | 204,61 1,049 |
97,036,053 | 26,132,856 |
128,218,236 | @027B3,405 |
1,t66,746B70 | 39,0t2,7J1 |
I75,47B534 | 31,549,367 |
J44,47014J | 278,769,852 |
1,305,735,092 | l,â00,84B7U5 |
318,3'71,385 | 432,595,276 |
t86,576,298 | 48,309.550 |
Issued, subscribed and paid up capital Share premium
190.000002
4,322,123,324
4,183,292,901
Unappropriaied profit | 2,6l6,766,03z 2,169,61 8,676 4,661@64i69 2,359,618,678 | ||||||
Nun-current limbñiiies- | |||||||
Storus, spsre txirls and loose tools | 19 | ||||||
Long term loans - secured | Stock in trade | 2iI | |||||
Long term musheraka - secured | 9 | Trade debls | 21 | ||||
Deferred grant Deferred taxation | 10 1I | Loans and advances Deposits, prepayments and other receivables | 22 *J | ||||
1,872,288,928 2.07t,7S3,53 I | Short term investments Advance income tax - net | ||||||
Cash and bank balances | |||||||
3,8J6,4U6,744 1,676,672,073 | |||||||
Current portion of: | |||||||
- Long term loans - recurred | 8 | ||||||
- Long ierm musharaka - secured | 9 | ||||||
- Deferred gtant | /0 | ||||||
Trade and other payables Centract liabilities Short term borrowings - secured Mark-up accrued on borrowings | /2 J3 J4 JJ | ||||||
1,624,276,971 t,428492,76S | |||||||
16 | |||||||
8,158,530,068 5,8s9,964,974 | 8,158,530,068 5,839,964,9?4 | ||||||
314,1120,402 | 292,719.538 |
14,1129,074 | |
114,108,411 | 125,451,492 |
1,116,096,032 | 622,636,797 |
20,150,923 | 2S,42t .875 |
29,362,548 | 328,698,729 |
16,509,571 | 33,664,334 |
The annexed notes from 1 to 47 form an integral part of these financial statements.
Chief Executive Officer
Statement ofProfit or Loss
2025 Rupees | 2024 Rupees | ||||
Revenue - net | 3,837,466,169 | 3,658,720,<87 | |||
Cost of goods sold | (3,549,634,820) | (2,126,213,134) | |||
Gross protit | 2,287,831,349 | 1,532,507,353 | |||
Administrative expenses | (60,568,184) | (40,494,d95) | |||
Selling and distribution expcnscs | (1,445,483,738) | (716,853,333) | |||
Other expenses | 30 | (70,575,816) | (64,226,543) | ||
Other income | 31 | 140,211,479 | 22,302,570 | ||
Profit from operations | 851,415,090 | 733,235,552 | |||
Finance cost | (127,676,712) | (l 51,3 56,821) | |||
Profit before income tax, final tax and | |||||
minimum tax differential | 723,738,378 | 581,878,73 1 | |||
4Iinimum tax differential | (3,198,833) | (2,155,750) | |||
Final tax | (4,117,333) | ||||
Profit before income taa | 720,539,545 | 575,605,648 | |||
Income tax | 35 | (273,392,189) | (190,192,46 I ) | ||
Profit after taaation | 447,1fi7,356 | J85,4lJ,187 | |||
Earnings per share - basic and diluted | 36 | 5.52 | 609 | ||
The annexed notes from 1 to 47 form an integral part of these financial statements.
Chief Executive Officer Chief Financial Officer Director
Statement of Comprehensive Income | ||||
For the year end:leJ 30 June -!3-!5 | ||||
2025 Rupees | 2024 Rupees | |||
Profit after taxation | 447,147,356 | 385,4 I 3.187 | ||
Items that will not be subseauentlv reclassiFiecl to oroht or loss | ||||
Other comprchensivc income tor the year | ||||
Total comprehensive income for the year | 8 .413,187 | |||
The annexed notes from I to 47 form an integral part of these financial statements.
Chief Executive Officer Chief Financia1 Officer Director
Statement of Changes in Equity
For the year ended 30 June 2025
Share capital | Capital reserve | Revenue reserve | Total |
Share premium | Unappropriated |
.Note
Balance as at 01 July 2023
Total comprehensive income for the yearProfit after taxation
Other comprehensive income for the year
Rounding off adjustment in lieu of shares splil arrangements
Balance as at 30 June 2024
Total comprehensive income (or the ye‹rr
Profit nfter taxntion
Other comprehensive income for the year
190,000,000
385,413,187 385,413,187
2
t90,000,002
1,784,205,491 1,974,203,491
385,413,187 385,413,187
(2)
- 2,169,618,676 2,359,618,678
447,147,356 447,147,356
447,147,356 447,147,356
Shares issued under initial public offering 6 & 7
Balance as at 30 June 2025
75,000,000 1,780,198, 135 l,8J5,198,l 35
265,000.002 1.780.198,135 2.616.766.032 4,661.96J.169
The annexed notes from 1 to 47 form an integral part of these financial statements.
Cash °enerated from operations before working capital changes
(Increa.se) •Iecrease in surreal a.s.sets Stores, spare pans and loose tools Stockin eade
Loans and advances • considered good Deposits, prepaymencs and other receivables
V6,836,015 410 332 096
Statement of Cash Flows | 2025 | 2024 | ||||
Rupces | ||||||
Profit after taxation Aulfusimenis for non-cash end uiher iiem.x: | 447,1J7.356 | 385,4 13, 187 | ||||
Depreciation on property, plani and equipment | 191,923,392 | |||||
Gain on disposal of property, plant and equipment | (2,790.880) | (2, 130,063) | ||||
1,691.585 | ||||||
Dividend income | 3I | (74,807,849) | (M8004 | |||
Finance cost | 123,982,196 | I49,849,868 | ||||
Interest expense on Workers' 9rofit Participatitiii Fund | 3,694.o16 | l,i06,953 | ||||
(Gain) / loss on re•measurement of shon term investments to tâir value | (2,306,246) | 107.363 | ||||
(Gain) / loss realized on sale of shori term invesmients | (2d,998,278) | (317.789) | ||||
Un-realized exchange loss / (gain) | (1,382.185) | |||||
Protii on bank deposits | (20,2 10.671) | (6,454,951 ) | ||||
minimum tax | 3.198.833 | 2. 155,750 4,117,3c a | ||||
Income ‹ax | 273,392,189 | 190, 192.46 i | ||||
Provision for Workers' Profit Participation Fund | 38,868,871 | 31.255,966 | ||||
Provision For Central Research Fund | 7,851297 | 6,3 14,337 | ||||
Provision fbr Workers' WslF«re Fund | l477Ol7I | 11 877 *67 |
795,743.283
t9,670.T94 | (3I, 181,938) |
(866,0T4.968) | ( 10,386,566) |
2n,368,888 | (110.819,310) |
(70,903.t97) | ( 11,885,567) |
7J,565,169 | ( 112 204 862) |
Trade and other payables Conrrac‹ Liabilities
Workers' Profit Participation Fund paid
Workers' Welfare Fund paid
72 2 9 7 0 90
5 27 9 1 88
467.l61.157 2 l6 499 7S7
628.771.2IJ 735,766,827
(279,052,608) | (31,389.859) |
(3.198.833) | ( I.789.003 |
(2,318,519) | |
(32,762J23) | ( 13.361,908 |
(6,3t4§37) | (2,!99,992 |
(7,658,057) |
(328.986,058) (7 1,063.28 I )
Fixed capital expenditure incurred
Proceeds from sale of property, plant and equipment
Dividend iacome
Net cagh used in investing activities
Long term loan paid Proceeds from IPO • net
Long term musharaka received
Financc cost paid
Net cash generated i'rom / (used in) financing activities
Net increase in cash and cash equivalents
299,78SJ56
(329.494,857) | ( 143, 130,915) |
3.861,386 | 4,404,596 |
7fi,807,849 | 12,850,074 |
( 1,100,429,375) | 108,583.fi78 |
(4,021,050) | (3,000,0001 |
20.210,671 | 6 484 951 |
(4 i8.270,946) | (321.357,447) |
l,855,198,13S | |
93,351,808 | |
( 17,916,58t) | |
t12,245,72J | f 161 S l9 981 |
(1,335.065,376)
1500,316.692
365,036.472
66•t.703.546
(13.fl07,816)
(482.877.428)
168,II 18,302
Cash and cash equivalents at the beginning of the year Cash and cash equivalents at the end of the year
(49.928,877) (217.947 179)
3IS,l 07 595 " (49 928 877)
Cash and cash equivalents comprise of the following: CashendbankbB‹mces
344,470.143
278.769,852
Shonterm bonowings-scctred
The:mncxcdno1os éoin l Do47formani1Sepalpartoftñ*se fnancia|s1Jcmenti
Cb ief Executive Officer Chief Financial Officer
t29,362,5d8) (328,698.729)
3I 5.107 595 (49 928 877) .Director